NCT03886701
- Conditions
- Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +24 more
- Locations
-
- Thomas Jefferson University Clinical Research Unit Philadelphia, Pennsylvania, United States
Clinical trial condition
Slow Virus Diseases
Explore clinical trials studying Slow Virus Diseases. Study availability and eligibility vary by location and protocol.
2,619 public trials
184 recruiting studies
Slow Virus Diseases trial results
Completed
A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761
NCT01031472
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
NCT01246401
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +22 more
- Locations
-
- Yale University Hartford, Connecticut, United States
- Yale University New Haven, Connecticut, United States
- Baystate Medical Center Springfield, Massachusetts, United States
Completed
Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS
NCT02140775
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
- Locations
-
- Callen-Lorde Community Health Center New York, United States
- New York State Psychiatric Institute New York, United States
Completed
Effectiveness of a Pre-adolescent Inter-generational Intervention to Address HIV and Obesity
NCT04307966
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Body Weight, +22 more
- Locations
-
- Kamogelo Primary school Westonaria, Gauteng, South Africa
- Westonaria primary school Westonaria, Gauteng, South Africa
- Westonaria primary mine school Westonaria, Gauteng, South Africa
- Zuurbekom Primary School Westonaria, Gauteng, South Africa
NCT03310515
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
- Locations
-
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Shenyang, Liaoning, China
- GSK Investigational Site Chengdu, Sichuan, China
- GSK Investigational Site Hangzhou, Zhejiang, China
Completed
Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults
NCT03045861
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Bakersfield, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Los Angeles, California, United States
NCT03186183
- Conditions
- Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +20 more
- Locations
-
- Health Initiative for Men Vancouver, British Columbia, Canada
- Regional HIV/AIDS Connection London, Ontario, Canada
- Immunodeficiency Clinic - The Ottawa Hospital Ottawa, Ontario, Canada
- Gay ZONE (Centretown Community Health Centre) Ottawa, Ontario, Canada
NCT03101852
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +18 more
- Locations
-
Not specified
Completed
Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART
NCT01869634
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- University of California Davis Sacramento, California, United States